By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Active Biotech AB 

Scheelev├Ągen 22

Lund    SE-220 07  Sweden
Phone: 46-46-19-10-00 Fax: 46-46-19-20-50




Company News
Annual General Meeting Of Active Biotech (BTPC) 6/16/2017 6:53:57 AM
Teva (TEVA), Active Biotech (BTPC) Suffer Another Setback After Laquinimod Flunks MS Study 5/8/2017 5:47:42 AM
Active Biotech (BTPC), NeoTX Ink $71 Million+ Immuno-Oncology Pact 10/26/2016 8:05:17 AM
FDA Takes Back Special Protocol Assessment for Active Biotech (BTPC)'s Laquinimod 9/19/2016 5:47:34 AM
Teva (TEVA), Active Biotech (BTPC) Stop Higher Doses of Laquinimod in Two Multiple Sclerosis Trials 1/4/2016 7:32:30 AM
Active Biotech (BTPC)'s Partner Teva (TEVA) Presents Data On Laquinimod For The Treatment Of Multiple Sclerosis At 31st ECTRIMS Congress 10/6/2015 8:00:35 AM
Teva (TEVA) And Active Biotech (BTPC) Announce Completion Of Patient Enrollment In Laquinimod Phase III CONCERTO Trial 6/25/2015 12:28:55 PM
Active Biotech (BTPC) Forced to Cut 47 of 56 Staffers After Phase III Prostate Cancer Failure 6/2/2015 7:11:58 AM
Teva (TEVA) And Active Biotech AB (BTPC) Announce First Patient Enrolled In Phase II Study Evaluating Laquinimod For Primary Progressive MS 4/23/2015 1:17:55 PM
Ipsen (IPN.PA), Active Biotech AB (BTPC) Plummet As Prostate Cancer Drug Flunks Late-Stage Trial 4/16/2015 10:23:37 AM